A People-Driven Research Organization
Executive Summary
In the battle for the hearts and minds of young scientists, drug companies are losing out to biotech companies and discovery boutiques. Big pharma needs to attract top talent in much the same way small companies do--creating pathways to allow scientists to achieve their professional and personal aspirations, providing an unmatched research environment, and offering competitive incentives and rewards. Making such opportunities available may push pharma companies beyond their comfort zone, but not making them available will be even worse.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.